Effect of the mGluR5-NAM Basimglurant on Behavior in Adolescents and Adults with Fragile X Syndrome in a Randomized, Double-Blind, Placebo-Controlled Trial: FragXis Phase 2 Results.

Effect of the mGluR5-NAM Basimglurant on Behavior in Adolescents and Adults with Fragile X Syndrome in a Randomized, Double-Blind, Placebo-Controlled Trial: FragXis Phase 2 Results. Neuropsychopharmacology. 2018 02; 43(3):503-512.

View in: PubMed

subject areas

Adolescent
Adult
DNA Methylation
Double-Blind Method
Excitatory Amino Acid Antagonists
Female
Fragile X Mental Retardation Protein
Fragile X Syndrome
Humans
Imidazoles
Male
Middle Aged
Psychotropic Drugs
Pyridines
Receptor, Metabotropic Glutamate 5
RNA, Messenger
Treatment Failure
Young Adult

authors with profiles

Elizabeth Berry-Kravis